Rothschild & Co Asset Management US’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
ACH
BG
NAMA
GS
Rothschild & Co Asset Management US's CDNA Position: Q4 2022 in Review
Rothschild & Co Asset Management US reduced its CareDx (CDNA) stake by 6.4% in Q4 2022, selling an estimated $268K and leaving 266,132 shares worth $3.04M. The position accounts for 0.05% of the portfolio, ranked #211.
Rothschild & Co Asset Management US first reported a position in CDNA in Q2 2022 and has held it in 3 quarters since. The position peaked at $6.11M in Q2 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.
- Rothschild & Co Asset Management US held 266,132 shares of CareDx worth $3.04M as of Q4 2022.
- Rothschild & Co Asset Management US sold 18,095 CareDx shares in Q4 2022, an estimated $268K.
- CareDx made up 0.05% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #211 holding.
- Rothschild & Co Asset Management US first reported a position in CareDx in Q2 2022 and has held it in 3 quarters since.
- Rothschild & Co Asset Management US's CareDx position peaked at $6.11M in Q2 2022.
- 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.